← Leaderboards
Anthony L Vaccarino
St. Charles Pharmaceuticals
$562,081
Attributed
$562,081
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$562,081 · 4
By mechanism
R43$308,542 · 3
R44$253,539 · 1
Top collaborators
No co-investigators on record.
Most similar at St. Charles Pharmaceuticals
Same institution · by research overlap
- Kenneth W Narducy$2,281,698
- Kenneth Wayne Narducy$1,061,192
Others in their field
Top investigators on “Laboratory Mouse”
- Richard K. Wilson · Washington University$122,948,010
- Frank Patrick McCormick · University Of California San Francisco$87,382,096
- David Heimbrook · Leidos Biomedical Research, Inc.$81,904,667
- Kc Kent Lloyd · University Of California At Davis$56,148,943
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,869,943
- Carol J Bult · Jackson Laboratory$47,860,052
Research focus
Laboratory MouseHepatotoxinDrug Design /Synthesis /ProductionAnalgesicsAcetaminophenAnalgesiaDrug Adverse EffectDrug Screening /EvaluationPainDrug Administration Rate /DurationTherapy Design /DevelopmentChemical StructureDrug HabituationDrug MetabolismPharmacokineticsDrug ToleranceGenetically Modified AnimalsGlutathioneCancer PainHistologyHuman Old Age (65+)Bone NeoplasmsLiver Toxic DisorderMetastasis
Grant awards (4)
Novel drug combinations for the management of pain$253,539
R44 · FY2005 · NS
Novel Analgesics for the Treatment of Bone Cancer Pain$109,305
R43 · FY2004 · CA
Novel Drug Combinations for Treating Pain in the Elderly$99,959
R43 · FY2003 · AG
Pain Relieving Properties of Analgesic Metabolites$99,278
R43 · FY2003 · NS